glp 1 meds and hashimoto's GLP-1: what thyroid patients need to know before starting GLP-1 and Inflammation: How These

Want the gentle lane explained? Read our guide to microdosing tirzepatide, or compare starting doses side by side in the GLP-1 microdosing dose chart

Sales of antiobesity drugs hit $1.1 billion in the second quarter of 2023.

What do GLP-1 weight loss drugs reveal about the cause of obesity

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective anti-glycemic and weight-loss medications with a strong safety record

New data is shedding light on a potential link between GLP-1 receptor agonists and long-term vision outcomes, with findings suggesting these therapies may be associated with a lower risk of legal blindness in patients with type 2 diabetes

This and other trials have shown improvements in patients lipid profiles with the most pronounced impact on reduction of triglycerides